NCT03996096View on ClinicalTrials.gov

Tyrosine Kinase Inhibitor Withdrawal Syndrome in CML Patients: Observatory Trial Studying the Biological Factors.

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

April 23, 2019

Primary Completion Date

March 16, 2023

Study Completion Date

March 16, 2023

Conditions
Chronic Myeloid LeukemiaTyrosine Kinase InhibitorWithdrawal Syndrome
Trial Locations (1)

14033

University hospital, Caen

All Listed Sponsors
lead

University Hospital, Caen

OTHER

NCT03996096 - Tyrosine Kinase Inhibitor Withdrawal Syndrome in CML Patients: Observatory Trial Studying the Biological Factors. | Biotech Hunter | Biotech Hunter